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Abstract: Non-homologous end-joining (NHEJ) is a major DNA repair pathway in mammalian
cells that recognizes, processes and fixes DNA damage throughout the cell cycle and is specifically
important for homeostasis of post-mitotic neurons and developing lymphocytes. Neuronal apoptosis
increases in the mice lacking NHEJ factors Ku70 and Ku80. Inactivation of other NHEJ genes, either
Xrcc4 or Lig4, leads to massive neuronal apoptosis in the central nervous system (CNS) that correlates
with embryonic lethality in mice. Inactivation of either Paxx, Mri or Dna-pkcs NHEJ gene results in
normal CNS development due to compensatory effects of Xlf. Combined inactivation of Xlf/Paxx,
Xlf/Mri and Xlf/Dna-pkcs, however, results in late embryonic lethality and high levels of apoptosis in
CNS. To determine the impact of NHEJ factors on the early stages of neurodevelopment, we isolated
neural stem and progenitor cells from mouse embryos and investigated proliferation, self-renewal
and differentiation capacity of these cells lacking either Xlf, Paxx, Dna-pkcs, Xlf/Paxx or Xlf/Dna-pkcs.
We found that XRCC4-like factor (XLF), DNA-dependent protein kinase catalytic subunit (DNA-PKcs)
and paralogue of XRCC4 and XLF (PAXX) maintain the neural stem and progenitor cell populations
and neurodevelopment in mammals, which is particularly evident in the double knockout models.
Keywords: DNA repair; NHEJ; synthetic lethality; genetic interaction
1. Introduction
Double-strand DNA breaks (DSBs) are common DNA damage events that threaten the
stability of our genome. DSBs can be repaired by homologous recombination (HR), classical
non-homologous end-joining (C-NHEJ, or simply NHEJ) and alternative end-joining (A-EJ,
also known as backup end joining, or microhomology-mediated end joining) [1–4]. HR is
only available during S/G2 cell cycle phases of the cell cycle when the sister chromatid
is accessible and then used as a template. C-NHEJ acts throughout the entire cell cycle,
sealing directly the broken ends and is the predominant repair pathway in mammalian
cells [3,5]. A-EJ is often microhomology-mediated and more obvious in the absence of
classical NHEJ [6].
C-NHEJ involves recognition of the DSBs by Ku70/Ku80 heterodimer (Ku), which
in turn recruits DNA-dependent protein kinase catalytic subunit (DNA-PKcs) to form a
DNA-PK holoenzyme complex that protects free DNA ends. Assembly of DNA-PK triggers
the autophosphorylation of DNA-PKcs, as well as DNA-PKcs-dependent phosphorylation
of multiple other DNA repair factors [3]. Ku facilitates recruitment of NHEJ proteins, such
as X-ray repair cross-complementing factor 4 (XRCC4)-like factor (XLF), a paralogue of
XRCC4 and XLF (PAXX), and a modulator of retrovirus infection (MRI). Ligation of the
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broken ends is performed by the NHEJ factor DNA Ligase 4 (LIG4), which is stabilized by
another protein, XRCC4 [1–4].
Genetic inactivation of Xrcc4 [7] or Lig4 [8] in mice results in p53-dependent late
embryonic lethality, which correlates with a massive apoptosis in the central nervous
system (CNS) [9,10]. Although Ku70−/− and Ku80−/− knockout mice are viable, they
present high levels of apoptosis in CNS and remarkable growth retardation [11,12].
Mice lacking NHEJ factors possess various phenotypes [1–4]. In particular, Dna-
pkcs−/− [13], Xlf−/− [14,15], Paxx−/− [2,16–20] and Mri−/− [1,2,21] knockout mice are
viable, displaying normal growth, lifespan, and neuronal development. However, inac-
tivation of DNA-PKcs kinase domain (Dna-pkcsKD/KD) leads to Ku- and p53-dependent
embryonic lethality, which correlates with high levels of apoptosis in the CNS [22]. Jiang
et al. identified more condensed apoptotic nuclei in the intermediate zone of mouse embry-
onic brain, suggesting that mutation in Dna-pkcs gene affects post-mitotic neurons. The
apoptotic neurons were relatively rare in the proliferating ventricular zone [22,23]. Thus, a
homozygous D3922A mutation in Dna-pkcs resulted in a neurological phenotype similar
to observed earlier for mice lacking XRCC4 or LIG4 [7–10,24], suggesting a defect in the
G0/G1 phase of the cell cycle, when NHEJ dominates. Contrary, phosphorylation of DNA-
PKcs’ S2038, S2053, S2026, S2050 and S2052 is likely not essential for NHEJ in postmitotic
neurons [25]. An impact of DSBs on neural stem and progenitor cells (NSPCs) fitness was
recently suggested by using wild type (WT) murine cells and ionizing radiation [26]. While
previous studies focused on apoptosis of mature neurons using in vivo NHEJ-deficient
mouse models, no attempts were made to address the role of specific NHEJ factors during
earlier development stages, e.g., proliferation, self-renewal capacity and differentiation
of NSPCs.
More recently, genetic interaction studies uncovered the importance of the NHEJ
factors XLF, DNA-PKcs, PAXX and MRI in the development of immune and nervous
systems and mouse development in general. Synthetic lethality was reported between Xlf
and Dna-pkcs [20,27,28], then between Xlf and Paxx [1,2,16,17,19,20], and finally between
Xlf and Mri [1,2,21]. These studies suggested that functions of DNA-PKcs, PAXX, and
MRI are partially compensated by XLF. While MRI-deficient NSPCs possessed reduced
proliferation and normal self-renewal capacity [29], no similar studies were performed on
NSPCs lacking XLF, DNA-PKcs, PAXX, XLF/PAXX or XLF/DNA-PKcs.
Here, using single and double knockout mouse models, we found that XLF, DNA-PKcs
and PAXX are required to maintain pluripotency of neural stem cells, including aspects of
self-renewal, proliferation, and differentiation to neurons and astrocytes.
2. Materials and Methods
2.1. Mice
All experimental procedures involving mice were performed according to the pro-
tocols approved by the Comparative Medicine Core Facility at Norwegian University of
Science and Technology (NTNU, Trondheim, Norway). Dna-pkcs+/− [13], Xlf +/− [14], and
Paxx+/− [18] mouse models were previously described. Dna-pkcs+/− and Xlf +/− mice were
imported from Professor Frederick Alt lab (Harvard Medical School and Boston Children’s
Hospital, Boston, MA, USA). Paxx+/− mice were generated by Oksenych group (NTNU,
Trondheim, Norway).
2.2. Mouse Genotyping
A conventional polymerase chain reaction (PCR) was used to determine the mouse
genotypes. DNA was isolated from ear punches by incubating overnight at 56 ◦C with
2% proteinase K in DNA lysis solution, containing 10 mM pH = 9.0 Tris, 1 M KCl, 0.4%
NP-40 and 0.1% Tween 20. Next, the samples were heat-treated for 30 min at 95 ◦C.
The PCR reactions were performed using GoTaq®G2 Green Master Mix (Promega, WI,
USA; #M7823) or Taq 2x Master Mix Kit (New England Biolabs® Inc., Ipswich, MA, USA;
#M0270L) according to the manufacturer’s instructions. Each reaction contained 50 ng of
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DNA and 0.8 µM of indicated primers (Supplementary Table S5) in a final volume of 25 µL.
The PCR product was revealed in a 0.7% agarose gel.
2.3. Neural Stem and Progenitor Cell Cultures
NSPCs were cultured as free-floating aggregates, also known as neurospheres [29,30].
Briefly, murine embryos were collected at embryonic day E15.5, the brains were isolated
and the cerebellums were removed. Remaining brain parts were mechanically disrupted in
proliferation medium, containing Dulbecco Modified Eagle Medium/Nutrient Mixture F12
(DMEM/F12), supplemented with 1% penicillin/streptomycin, 2% B27 without vitamin
A (Thermo Fischer Scientific, Waltham, MA, USA), 10 ng/mL epidermal growth factor
(EGF) and 20 ng/mL basic fibroblast growth factor (bFGF). The neurospheres were formed
and incubated at 37 ◦C, 5% CO2 and 95% humidity. The neurospheres were dissociated
every seventh day using 0.25% of trypsin in ethylenediaminetetraacetic acid (EDTA), as
previously described in Castaneda-Zegarra et al. (2019) and Wang et al. (2010) [29,30].
For more details, see also Supplementary Materials and Methods. The neurospheres from
passages 3 to 10 were used in all the experiments.
2.4. Proliferation Assay
NSPCs’ proliferation rates were analyzed using PrestoBlue™ Cell Viability Assay
(Thermo Fisher Scientific, Waltham, MA, USA; A13261) following the manufacturer’s
protocol and as described in Xing and Oksenych (2019) [31]. Briefly, 0.25% trypsin-EDTA
was used to obtain single NSPCs, which were then plated onto a 96-well-suspension plate
at 8000 cells per well in proliferation medium and incubated at 37 ◦C, 5% CO2 and 95%
humidity. At day 3, PrestoBlue™ was added to final concentration of 10% in proliferation
medium in each well, and the cells were incubated for 2 h at 37 ◦C, 5% CO2 and 95%
humidity before measuring the fluorescence intensity using FLUOstar Omega system
(BMG Labtech, Ortenberg, Germany), 570 nm. The fluorescence intensity indicates the
proportion of live cells. The NSPC proliferation assay was carried out on 6 replicates per
clone, in 3 independent experiments.
2.5. Self-Renewal Capacity Assay
For self-renewal assay, we followed the protocol described earlier [29]. Briefly, the
capacity of neural stem cells to maintain their multipotency ex vivo was assessed by deter-
mining the number and two-dimensional size of neurospheres. Dissociated single NSPCs
were plated onto 6-well suspension plates containing proliferation medium (day 0). At day
8, images of the entire wells were captured using the EVOS microscope (Invitrogen, Carls-
bad, CA, USA). The pictures were analyzed using the ImageJ software (NIH, Bethesda, MD,
USA) to obtain the total number of neurospheres per well and size of spheres (pixels, px).
2.6. Differentiation Assay
Differentiation was induced in dissociated NSPCs, as described previously [29,30].
Briefly, 25,000 single NSPCs were cultured onto 48-well plates pre-coated with 30 µg/mL
poly-D-lysine and 2 µg/mL laminin, with differentiation medium containing NeuroBasal A
medium (Thermo Fischer Scientific, USA) supplemented with 1% penicillin/streptomycin,
2% B27, 1% GlutaMAX and 10 ng/mL bFGF (day 0) (also see Supplementary Materials
and Methods). On day 5, the differentiated cells were fixed with 4% paraformaldehyde
for 15 min at room temperature. Furthermore, immunostaining was performed using
antibodies recognizing either the neuron-specific β-III tubulin (Tuj1) or the glial fibrillary
acidic protein (GFAP) proteins, to determine neurons and astrocytes respectively after
differentiation [29,30]. Briefly, the cells were permeablized with 0.1% Triton X-100 for
30 min, washed 3 times with phosphate-buffered saline (PBS) (Oxoid Limited, Basingstoke,
UK), and blocked with 1:2 dilution of blocking solution containing 10% BSA (Sigma, USA),
10% goat serum (Invitrogen, USA) and 0.1% Triton X-100 (Sigma, USA) for an hour, and
washed with PBS. Then, the cells were incubated with the indicated primary antibodies
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in 10% blocking solution for one hour at room temperature and washed with PBS. Next,
the cells were incubated for one hour with the secondary fluorescent marker-conjugated
antibodies at room temperature and counterstained with 1 µg/mL of 4′6-diamidino-2-
phenylindole (DAPI, Molecular Probes, Eugene, OR, USA). Images were collected using
the EVOS microscope. Positively-stained cells were counted using ImageJ software and
presented as a proportion of total cells normalized to WT control.
2.7. Western Blot
Western blots were performed using antibodies against XLF, PAXX, DNA-PKcs, and
β-actin (Supplementary Materials and Methods) [18,31,32]. Neurospheres were collected
and lysed with radioimmunoprecipitation assay buffer (RIPA, Sigma, USA) containing
cOmplete™ EDTA-free Protease Inhibitor Cocktail (Roche, Branchburg, NJ, USA) and 1
mM phenylmethanesulfonyl fluoride (PMSF, Sigma, USA). Protein concentrations were
determined by Bradford assay (Biorad, Hercules, CA, USA). Further, 40 µg of protein from
each clone was analyzed by the sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Proteins were transferred to the membranes using XCell II™ Blot Module
(ThermoFisher Scientific, Waltham, MA, USA) at 4 ◦C. Then, the membranes were blocked
with 5% milk in PBS with 10% Tween 20 (PBST) for one hour at room temperature. Primary
antibodies were incubated overnight at 4 ◦C, rinsed with PBST 3 times for 5 min and
incubated with the secondary antibodies for one hour at room temperature. The blot was
washed and incubated with SuperSignal™ West Femto (Thermo Fischer Scientific, USA) to
reveal the proteins with ChemiDoc™ Touch Imaging System (BioRad, USA).
2.8. Statistical Analysis
To analyze the data, we pulled together two clones per genotype, representing an in-
dependent mouse embryo each, and performed three independent experiments with every
clone. All the data shown were normalized to WT average levels. To find statistical differ-
ences among the genotypes, Kruskal-Wallis test with Dunn’s multiple comparisons test, as a
non-parametric alternative of one-way ANOVA, was used. The statistical analyses were per-
formed using GraphPad Prism 7.03 software (GraphPad Prism, La Jolla, CA, USA) [29,30].
3. Results
3.1. Impact of XLF, PAXX, and DNA-PKcs on Proliferation and Self-Renewal Capacity of Neural
Stem and Progenitor Cells
Single knockout of NHEJ genes Xlf, Dna-pkcs or Paxx results in viable fertile mice with-
out detectable phenotypes in the CNS [13–19]. Contrary, combined inactivation of Xlf and
Dna-pkcs [20,27,28], or Xlf and Paxx [2,16,17,19,20] results in a synthetic lethality (Figure 1A).
To further investigate the impact of XLF, DNA-PKcs, and PAXX on the nervous system de-
velopment, we isolated NSPCs from WT, Xlf−/−, Paxx−/−, Dna-pkcs−/−, Xlf−/−Paxx−/−,
and Xlf−/−Dna-pkcs−/− mouse embryos (E15.5). NSPCs aggregated themselves form
neurospheres within 7 days in culture. We used these neurospheres to characterize prolifer-
ation, self-renewal, and neural differentiation capacity of the NSPCs (Figure 1C).
To obtain Xlf−/−Paxx−/− embryos, we intercrossed Xlf−/−Paxx+/− mice. As we
observed previously [20], no live-born Xlf−/−Paxx−/− pups were detected (0), while
we recorded Xlf−/−Paxx+/+ (16) and Xlf−/−Paxx+/− (27) live-born mice (Figure 1A).
By analyzing E15.5 embryos in the same breedings, we detected Xlf−/−Paxx−/− (3),
Xlf−/−Paxx+/+ (8) and Xlf−/−Paxx+/− (31) mice (Figure 1B), which were later used for the
neurosphere generation and characterization. Xlf−/−Dna-pkcs−/− mice were described
earlier [20]. Briefly, by breading Xlf−/−Dna-pkcs+/−mice, we obtained no adult Xlf−/−Dna-
pkcs−/− mice (0), while there were Xlf−/−Dna-pkcs+/+ (35) and Xlf−/−Dna-pkcs+/− (54)
mice at day P30. However, live-born Xlf−/−Dna-pkcs−/− mice were detected at days
P1–2, in line with our previous observations [20,27,28]. We confirmed the lack of protein
expression in the knockout cells by western blot (Figure 2A and Supplementary Figure S1).
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Detailed statistical analysis for the relative size of neurospheres (self-renewal),
Figure 2D. WT vs. Xlf−/− (*, p = 0.0167); WT vs. Paxx−/− (ns, p > 0.9999); WT vs. Dna-
pkcs−/− (****, p < 0.0001); WT vs. Xlf−/−Paxx−/− (ns, p = 0.7434); WT vs. Xlf−/−Dna-
pkcs−/− (****, p < 0.0001); Xlf−/− vs. Paxx−/− (**, p = 0.0028); Xlf−/− vs. Dna-pkcs−/−
(***, p = 0.0009); Xlf−/− vs. Xlf−/−Paxx−/− (ns, p = 0.1897); Xlf−/− vs. Xlf−/−Dna-
pkcs−/− (*, p = 0.0134); Paxx−/− vs. Dna-pkcs−/− (***, p = 0.0002); Paxx−/− vs. Xlf−/−
Paxx−/− (ns, p > 0.9999); Paxx−/− vs. Xlf−/−Dna-pkcs−/− (**, p = 0.0033); Dna-pkcs−/− vs.
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Xlf−/−Paxx−/− (*, p = 0.0241); Dna-pkcs−/− vs. Xlf−/−Dna-pkcs−/− (ns, p > 0.9999);
Xlf−/−Paxx−/− vs. Xlf−/−Dna-pkcs−/− (ns, p > 0.2116).
By analyzing the neurosphere cultures, we observed that the average proliferation
rates of Xlf−/−Paxx−/− and Xlf−/−Dna-pkcs−/− double knockout neurospheres were
reduced when compared to WT and single-deficient Xlf−/−, Dna-pkcs−/− or Paxx−/−
neurospheres (Figure 2B). To quantify the self-renewal capacity of neurospheres, we plated
10,000 NSPCs and counted the formed neurospheres at day 8 in culture (Figure 2C). In-
activation of Xlf resulted in 20% reduction and inactivation of Paxx resulted in a 40%
reduction of neurosphere count when compared to WT controls. Combined inactivation
of Xlf and Paxx resulted in about 80% reduction of neurosphere count (Figure 2C), fur-
ther highlighting the severe neurological phenotype of Xlf−/−Paxx−/− mice observed
in vivo [16,17,19]. Surprisingly, inactivation of Dna-pkcs resulted in a higher number of
viable neurospheres, although of smaller size. Combined inactivation of Xlf and Dna-pkcs
resulted in neurosphere count similar to WT controls. We concluded that inactivation of
Xlf and Paxx affected self-renewal capacity and viability of NSPCs (Figure 2C).
To determine neurosphere growth rate, we used an alternative quantification based
on the image size in pixels (px) (Figure 2D). Inactivation of Xlf, Dna-pkcs, or both Xlf/Dna-
pkcs, resulted in neurospheres with 30% to 50% reduction in size when compared to WT
controls. Inactivation of Paxx did not affect the size of neurospheres in WT and Xlf -deficient
backgrounds (Figure 2D). We concluded that both XLF and DNA-PKcs support growth of
NSPCs in neurospheres.
3.2. Impact of XLF, PAXX, and DNA-PKcs on Differentiation Capacity of Neural Stem and
Progenitor Cells
To determine whether XLF, PAXX, and DNA-PKcs affect neural differentiation capac-
ity, single NSPCs (25,000 cells) were plated on pre-coated 48-well plates and cultured with
differentiation medium for 5 days. Neuronal and glial lineages were identified by immuno-
labeling using markers for early neurons (Tuj1), and astrocytes (GFAP). Inactivation of
Xlf, Paxx or Dna-pkcs, and combined inactivation of Xlf /Paxx did not affect early neuronal
differentiation based on average proportions of Tuj1-positive cells (Figure 3A). Combined
inactivation of Xlf and Dna-pkcs, however, resulted in two-fold reduced neurodifferentia-
tion capacity of NSPCs (Figure 3A,C). The proportion of GFAP-positive glial lineage cells
increased, although not significantly, when NSPCs were lacking either XLF or PAXX, or
both XLF and PAXX (Figure 3B,D).
Detailed statistical analysis for the neuron differentiation, Figure 3C. WT vs. Xlf−/−
(ns, p > 0.9999); WT vs. Paxx−/− (ns, p > 0.9999); WT vs. Dna-pkcs−/− (ns, p > 0.9999);
WT vs. Xlf−/−Paxx−/− (ns, p > 0.9999); WT vs. Xlf−/−Dna-pkcs−/− (ns, p = 0.0962);
Xlf−/− vs. Paxx−/− (ns, p > 0.9999); Xlf−/− vs. Dna-pkcs−/− (ns, p > 0.9999); Xlf−/− vs.
Xlf−/−Paxx−/− (ns, p > 0.9999); Xlf−/− vs. Xlf−/−Dna-pkcs−/− (ns, p = 0.9081); Paxx−/−
vs. Dna-pkcs−/− (ns, p > 0.9999); Paxx−/− vs. Xlf−/−Paxx−/− (ns, p > 0.9999); Paxx−/− vs.
Xlf−/−Dna-pkcs−/− (ns, p = 0.2067); Dna-pkcs−/− vs. Xlf−/−Paxx−/− (ns, p > 0.9999); Dna-
pkcs−/− vs. Xlf−/−Dna-pkcs−/− (ns, p > 0.9999); Xlf−/−Paxx−/− vs. Xlf−/−Dna-pkcs−/−
(ns, p > 0.9999).
Detailed statistical analysis for the astrocyte differentiation, Figure 3D. WT vs. Xlf−/−
(ns, p > 0.9999); WT vs. Paxx−/− (ns, p > 0.9999); WT vs. Dna-pkcs−/− (ns, p > 0.9999);
WT vs. Xlf−/−Paxx−/− (ns, p > 0.9999); WT vs. Xlf−/−Dna-pkcs−/− (ns, p > 0.9999);
Xlf−/− vs. Paxx−/− (ns, p > 0.9999); Xlf−/− vs. Dna-pkcs−/− (ns, p > 0.9999); Xlf−/− vs.
Xlf−/−Paxx−/− (ns, p = 0.0838); Xlf−/− vs. Xlf−/−Dna-pkcs−/− (ns, p > 0.9999); Paxx−/−
vs. Dna-pkcs−/− (ns, p > 0.9999); Paxx−/− vs. Xlf−/−Paxx−/− (ns, p > 0.9999); Paxx−/− vs.
Xlf−/−Dna-pkcs−/− (ns, p > 0.9999); Dna-pkcs−/− vs. Xlf−/−Paxx−/− (ns, p = 0.1392); Dna-
pkcs−/− vs. Xlf−/−Dna-pkcs−/− (ns, p > 0.9999); Xlf−/−Paxx−/− vs. Xlf−/−Dna-pkcs−/−
(ns, p = 0.5142).
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Overall, XLF possesses functional redundancy with PAXX during the NSPC self-
renewal, and with DNA-PKcs during cell growth and neuronal differentiation
(Figures 2 and 3).
4. Discussion
Here, w demonstrated that NHEJ factors XLF, PA X a d DNA-PKcs support prolifer-
ation of NSPCs during early mammalian neurogenesis, when the proliferation rate is high
and the likelihood of DNA damages arising from DNA replication machinery is in reased.
In Xrcc4−/−, Lig4−/−, Xlf−/−Paxx−/ and Xlf−/−Dna-pkcs−/− mice NHEJ is ablated.
Therefore, to avoid increased genomic instability during proliferation, developing neurons
undergo programmed cell death via the p53-dependent pathway [2,9,10,16,17,19,20,27,28].
In particular, we found that proliferation of Xlf−/−, Xlf−/−Paxx−/− and Xlf−/−Dna-
pkcs−/− NSPCs is significantly lower than that in WT cells; proliferation of Xlf−/−Dna-
pkcs−/− NSPCs is lower than that in Paxx−/− cells (Figure 2B). However, the difference
between the proliferation rates in XLF/PAXX or XLF/DNA-PKcs double-deficient NSPCs
is not different from single deficient controls, and proliferation rates of PAXX- or DNA-
PKcs-deficient NSPCs are not different from WT controls, suggesting that the effect is
XLF-dependent and it is more prominent when two factors are inactivated (either XLF and
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PAXX or XLF and DNA-PKcs, Figure 2B). It was previously shown that the expression and
activity of DNA-PKcs are increased in the NSPC murine cells when compared to mouse
embryonic fibroblasts [26], suggesting that DNA-PKcs can be essential for homeostasis
of NSPCs. Expression and activity of NHEJ vary in different cell types and require closer
attention in future research [33]. Our data further highlighted this observation, and our
findings suggest that the DNA-PKcs is required for NSPC proliferation and self-renewal
capacities, although its role is partially compensated by XLF (Figure 2B,C).
Self-renewal capacity was significantly affected in NSPCs lacking XLF, PAXX or both
XLF/PAXX, based on the cell number. However, inactivation of XLF or both XLF/DNA-
PKcs did not change self-renewal of NSPCs when compared to WT controls (Figure 2C).
Size of neurospheres is significantly reduced when XLF, DNA-PKcs or both XLF/DNA-
PKcs are inactivated (Figure 2D). Moreover, lack of DNA-PKcs resulted in neurospheres of
smaller size when compared to XLF- or PAXX-deficient samples (Figure 2D).
Finally, differentiation of NSPCs towards neurons or astrocytes was not significantly
affected when the cells were lacking either XLF, DNA-PKcs, or PAXX (Figure 3). Never-
theless, we observed a trend towards reduced Tuj1+ neurons in cell populations lacking
both XLF and DNA-PKcs (Figure 3A) when compared to WT and single-deficient controls.
In addition, we observed a potential trend towards increased GFAP+ astrocytes in cell
populations lacking either XLF, or PAXX, or both XLF and PAXX, when compared to WT
controls (Figure 3B).
Overall, our data suggest that PAXX is required for self-renewal of NSPCs, while
DNA-PKcs is essential for cell proliferation and growth of neurospheres (Figure 2B–D).
None of the NHEJ proteins studied (XLF, DNA-PKcs, PAXX) was essential for the NSPC
differentiation to neurons or astrocytes. Further analyses of early neurodevelopment
in vivo and in vitro will help to reveal new insights regarding the role of NHEJ factors in
neurodevelopment. Double- and multiple-knockout genetic models will facilitate these
studies unraveling functional redundancy between the DNA repair factors.
Here, for the first time, we directly addressed the roles of NHEJ factors XLF, PAXX
and DNA-PKcs in the processes of proliferation, self-renewal and differentiation of NSPCs.
The roles of XLF and PAXX in neurodevelopment were previously characterized using
murine embryonic brains, and the mouse embryos lacking both XLF and PAXX possessed
increased neuronal apoptosis when compared to single-deficient and WT controls [16,17,19].
However, no previous studies involved NSPCs lacking XLF, PAXX or both XLF and PAXX.
Furthermore, combined inactivation of XLF and DNA-PKcs resulted in ablated NHEJ and
perinatal lethality of XLF/DNA-PKcs double deficient mice [27]. It was later suggested that
the mice lacking both XLF and DNA-PKcs possess, among others, neurological defects [1,3];
however, no direct tests of this option were previously published. NSPC models were used
to demonstrate that NHEJ factor XRCC4 as well as DNA damage response factor ataxia
telangiectasia-mutated (ATM) are required for neuronal development, e.g., likely to repair
DSBs, including ones in the long neural genes [34–37]. The DSB repair and DNA damage
signaling were later more generally suggested to be required for healthy brain development,
using macrocephaly and autism spectrum disorder-derived NSPCs [38]. Finally, it was
recently demonstrated that regional regulator Filia is required for neurodevelopment. In
this study, both murine hippocampus and the NSPCs’ research models were used [39].
Although mice lacking XLF possess normal CNS development [14,15], human patients
with mutations in Cernunnos/XLF gene suffer from neurological defects, in addition to
immunodeficiency [40,41]. The difference between human and murine phenotypes might
be related to the fact that multiple NHEJ and DNA damage response factors, e.g., ATM and
H2AX [42], MDC1 [43], 53BP1 [44,45], DNA-PKcs [27], PAXX [2,16,17,19,20], MRI [2,21]
and RAG2 [46], partially compensate for the lack of XLF in mice. In other words, XLF
compensates for the lack of multiple factors, including DNA-PKcs and PAXX. Our recent
observations revealed that DNA-PKcs and PAXX are likely in the same sub-pathway of
NHEJ because Dna-pkcs−/−Paxx−/− mice and human cells do not possess any additional
phenotype when compared to the Dna-pkcs−/− or Paxx−/− mice and cells [20,31]. In
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particular, human HAP1 cell lines lacking both DNA-PKcs/PAXX possess the same levels of
genomic instability and sensitivity to DNA damage-inducing agents etoposide, doxorubicin
and bleomycin as DNA-PKcs-deficient ones [20,31]. Moreover, mice lacking both DNA-
PKcs and PAXX are live-born, fertile and do not show any additional phenotype when
compared to immunodeficient Dna-pkcs−/− knockout mice [20].
An important question challenging current research is: what is the mechanism under-
lying genetic interaction between Xlf and other NHEJ and DNA damage response (DDR)
factors in cells? As one option, it was suggested that XLF can be complementary to the
second factor having an alternative function (e.g., structural vs. enzymatic functions in
XLF/ATM or XLF/DNA-PKcs double mutants). Alternatively, the proteins can be com-
pletely redundant key structural components of NHEJ machinery (in XLF/DNA-PKcs,
XLF/MRI, XLF/PAXX, XLF/MDC1, XLF/53BP1, and XLF/RAG double mutants) [1,3,4].
Several models have been proposed to explain the DSB repair via NHEJ. A two-stage model,
where DNA ends are first tied in a complex [47]. More specifically, first, Ku70-Ku80-DNA-
PKcs (DNA-PK holoenzyme) form the initial complex, where DNA ends are sufficiently
distant. Next, a larger complex is formed by DNA-PK, XLF, LIG4 and XRCC4 [47]. More
recently, the XLF was proposed to be a flexible connector in this model, by interacting with
both Ku70/Ku80 and XRCC4/LIG4/DSB [48].
Another model suggests that there are two major structural complexes formed during
the NHEJ. Ku70-Ku80-XRCC4-LIG4 form the flexible synaptic complex (FS). Next, DSBs are
brought together through interaction of XRCC4, giving rise to two Ku-XRCC4-Lig4-DNA
complexes. Both XLF and PAXX are required for transition from the flexible synaptic to the
second synaptic complex, or close synapsis (CS). Here, XLF stabilizes the close synapsis to
a greater extent. In this model, it was suggested that DNA-PKcs is not involved in the FS
and CS formation [49,50]. Moreover, the structural roles of MRI [21] and PAXX [19] were
shown in the NHEJ, explaining the functional redundancy of these factors with XLF.
5. Conclusions
XLF is functionally redundant with PAXX during the neuronal stem and progenitor
cells self-renewal and proliferation, and with DNA-PKcs during cell growth and neuronal
differentiation. The NHEJ factors DNA-PKcs, PAXX and XLF are required for efficient
early-stage development of neuronal stem and progenitor cells in mice. Additional NHEJ
factors, such as MRI/Cyren, Ku70, Ku80, XRCC4 and LIG4, as well as multiple ATM-
dependent DDR factors might have similar functions in neurodevelopment. Future studies
will directly address the roles of NHEJ factors, including XLF, DNA-PKcs, PAXX and MRI,
in learning, memory and mood regulations.
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